BioLineRx Ownership | Who Owns BioLineRx?


OverviewRevenueFinancialsChartTranscripts

BioLineRx Ownership Summary


BioLineRx is owned by 2.93% institutional investors, 8.54% insiders, and 88.53% retail investors. Alyeska investment group is the largest institutional shareholder, holding 2.70% of BLRX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in BioLineRx shares.

BLRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioLineRx2.93%8.54%88.53%
SectorHealthcare Stocks 49.65%8.78%41.57%
IndustryBiotech Stocks 46.85%8.74%44.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Alyeska investment group1.95M2.70%$1.11M
Cvi815.68K1.13%$461.68K
Envestnet asset management213.83K0.30%$121.86K
Values first advisors203.76K0.28%$116.12K
Pvg asset management123.58K0.17%$70.43K
Susquehanna group, llp110.50K0.15%$62.98K
Atria investments104.78K0.14%$59.72K
Atria wealth solutions99.33K0.14%$56.61K
Lpl financial82.00K0.11%$46.73K
Cetera investment advisers71.67K0.10%$40.84K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cvi815.68K0.40%$461.68K
Pvg asset management123.58K0.28%$70.43K
Values first advisors203.76K0.07%$116.12K
Orin green financial43.00K0.01%$24.51K
Alyeska investment group1.95M0.01%$1.11M
Weaver consulting group16.92K0.00%$9.64K
Cutter & co brokerage16.67K0.00%$9.50K
Geneos wealth management38.50K0.00%$21.95K
Nemes rush group12.00K0.00%$6.84K
Atria investments104.78K0.00%$59.72K

Top Buyers

HolderShares% AssetsChange
Alyeska investment group1.95M0.01%1.95M
Cvi815.68K0.40%815.68K
Envestnet asset management213.83K-159.43K
Pvg asset management123.58K0.28%123.58K
Atria investments104.78K0.00%104.78K

Top Sellers

HolderShares% AssetsChange
Morgan stanley68.44K--222.92K
Susquehanna group, llp110.50K--61.60K
Two sigma securities---46.23K
Xtx topco---31.49K
B. riley wealth advisors---21.30K

New Positions

HolderShares% AssetsChangeValue
Alyeska investment group1.95M0.01%1.95M$1.11M
Cvi815.68K0.40%815.68K$461.68K
Pvg asset management123.58K0.28%123.58K$70.43K
Atria investments104.78K0.00%104.78K$59.72K
Orin green financial43.00K0.01%43.00K$24.51K

Sold Out

HolderChange
Simplex trading-1.98K
Group one trading-3.19K
B. riley wealth advisors-21.30K
Xtx topco-31.49K
Two sigma securities-46.23K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202433-2,340,493-44.99%28.50%12-25.00%1157.14%
Jun 30, 2024323.23%4,254,526223.98%5140.48%166.67%6-14.29%
Mar 31, 202431-3.13%1,313,19916.03%261.24%1566.67%7-22.22%
Dec 31, 202332-1,131,791-16.38%137.76%9-43.75%950.00%
Sep 30, 20233218.52%1,353,5169.38%254.39%1645.45%620.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index39.99K0.05%-

BLRX Ownership FAQ


Who Owns BioLineRx?

BioLineRx shareholders are primarily institutional investors at 2.93%, followed by 8.54% insiders and 88.53% retail investors. The average institutional ownership in BioLineRx's industry, Biotech Stocks , is 46.85%, which BioLineRx falls below.

Who owns the most shares of BioLineRx?

BioLineRx’s largest shareholders are Alyeska investment group (1.95M shares, 2.70%), Cvi (815.68K shares, 1.13%), and Envestnet asset management (213.83K shares, 0.30%). Together, they hold 4.12% of BioLineRx’s total shares outstanding.

Does Blackrock own BioLineRx?

BlackRock is not among the top 10 institutional shareholders of BioLineRx.

Who is BioLineRx’s biggest shareholder by percentage of total assets invested?

Cvi is BioLineRx’s biggest shareholder by percentage of total assets invested, with 0.40% of its assets in 815.68K BioLineRx shares, valued at 461.68K$.

Who is the top mutual fund holder of BioLineRx shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of BioLineRx shares, with 0.05% of its total shares outstanding invested in 39.99K BioLineRx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools